Inhibition of synucleinopathic seeding by rationally designed inhibitors
Seeding, in the context of amyloid disease, is the sequential transfer of pathogenic protein aggregates from cell-to-cell within affected tissues. The structure of pathogenic seeds provides the molecular basis and enables rapid conversion of soluble protein into fibrils. To date, there are no inhibi...
Main Authors: | Smriti Sangwan, Shruti Sahay, Kevin A Murray, Sophie Morgan, Elizabeth L Guenther, Lin Jiang, Christopher K Williams, Harry V Vinters, Michel Goedert, David S Eisenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/46775 |
Similar Items
-
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01) -
Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain
by: Rachel Kelly, et al.
Published: (2022-01-01) -
The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
by: Nicole K. Polinski, et al.
Published: (2022-06-01) -
Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation
by: Katharina Pieger, et al.
Published: (2022-08-01) -
Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
by: Dominika Fricova, et al.
Published: (2020-11-01)